Drug Substance Manufacturing - Microbial Fermentation

Drug Substance Manufacturing - Microbial Fermentation

Products
Drug Substance Manufacturing - Microbial Fermentation
Drug Substance Manufacturing - Microbial Fermentation

Information

12,000 L commercial manufacturing capacity in multi-licensed facility Two trains each with 6,000 L of capacity which can be used with flexible scales Large-scale GMP facilities licensed by EMA, FDA & MHLW for clinical and commercial global supplies Protein refolding, large-scale HPLC, explosion proof units, chemical modifications to prolong molecule half-life and purification-only for all kind of recombinant proteins from microbial technologies Several plasmid-based gene expression systems for E. coli, yeast and Pseudomonas Process and analytical development GMP batch release testing Manufacturing of Fab fragment, peptide hormones, plasmid DNA, scaffolds, recombinant proteins, enzymes and recombinant vaccines like VLPs
All Categories
Biomanufacturing
Main Categories
Biopharmaceutical Products
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied From
Austria
Boehringer Ingelheim Biopharmaceuticals GmbHBoehringer Ingelheim BioXcellence(TM) is the contract manufacturing arm of Boehringer Ingelheim and we have built a reputation as a reliable, world-class partner for biopharmaceuticals development and manufacturing. With facilities located in the USA, Europe, and Asia, we specialize in mammalian and microbial contract manufacturing, leveraging over 40 years of biotechnology expertise. We offer the full spectrum of services for late-stage products - with a hard-won reputation as a reliable partner accompanying you throughout the lifecycle of your product. Our trac...

Log in

See all the content and easy-to-use features by logging in or registering!